| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.147 | 36.848 | 34.870 | 32.909 | 37.962 | 44.397 | 117.298 | 50.511 | 41.676 | 33.493 |
| Total Income - EUR | 24.707 | 37.264 | 35.142 | 33.261 | 38.397 | 44.198 | 117.671 | 50.690 | 42.491 | 49.413 |
| Total Expenses - EUR | 8.121 | 13.310 | 13.503 | 25.881 | 21.761 | 55.001 | 84.625 | 47.914 | 60.421 | 58.628 |
| Gross Profit/Loss - EUR | 16.586 | 23.954 | 21.639 | 7.380 | 16.637 | -10.803 | 33.046 | 2.776 | -17.930 | -9.215 |
| Net Profit/Loss - EUR | 15.860 | 22.849 | 20.593 | 7.051 | 16.257 | -11.247 | 31.873 | 2.271 | -18.348 | -9.701 |
| Employees | 1 | 1 | 1 | 1 | 1 | 4 | 4 | 3 | 3 | 4 |
Check the financial reports for the company - Biomed Co. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.324 | 33.118 | 32.541 | 28.326 | 24.506 | 24.007 | 20.266 | 17.110 | 15.566 | 14.946 |
| Current Assets | 39.331 | 60.373 | 63.037 | 51.682 | 63.070 | 58.690 | 69.762 | 63.741 | 51.660 | 39.719 |
| Inventories | 14.518 | 16.238 | 13.589 | 9.686 | 11.899 | 8.624 | 6.783 | 8.108 | 6.405 | 4.037 |
| Receivables | 21.306 | 40.097 | 48.638 | 38.636 | 44.924 | 33.602 | 33.268 | 28.269 | 22.097 | 18.912 |
| Cash | 3.507 | 4.038 | 810 | 3.360 | 6.247 | 16.464 | 29.712 | 27.364 | 23.158 | 16.770 |
| Shareholders Funds | 13.061 | 35.776 | 40.373 | 26.467 | 35.298 | 10.352 | 41.995 | 23.456 | 2.773 | -6.943 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 57.483 | 53.001 | 50.231 | 48.705 | 47.538 | 67.706 | 43.479 | 52.828 | 60.112 | 58.080 |
| Income in Advance | 349 | 346 | 340 | 334 | 327 | 321 | 314 | 315 | 314 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Biomed Co. Srl